Alexx Ekubo.
The Nigerian entertainment industry has been thrown into mourning following reports that Nollywood actor Alexx Ekubo has died at the age of 40 after a battle with advanced metastatic kidney cancer.
According to a statement released by his family via his Instagram page, the actor passed away on Monday at Evercare Hospital following complications linked to stage 4 kidney cancer, also known medically as metastatic renal cell carcinoma.
The family described his final days as a period marked by courage and resilience, noting that he endured the illness with “remarkable strength, unwavering faith, and enduring hope.”
His death has triggered widespread reactions across Nollywood and social media, with colleagues, fans, and industry stakeholders paying tribute to his career and personal impact.
What is metastatic kidney cancer?
Metastatic kidney cancer is an advanced form of Kidney cancer. It occurs when cancer cells originating in the kidneys spread beyond the primary site to other parts of the body. At this stage, it is classified as stage 4, the most advanced and life-threatening phase of the disease.
Unlike early-stage kidney cancer, metastatic disease is not confined to the kidney and typically involves distant organs such as the lungs, bones, liver, or brain.
Key facts about metastatic kidney cancer
1. A relatively common but serious cancer
Kidney cancer ranks among the top 15 most common cancers globally. Hundreds of thousands of new cases are diagnosed each year, and it accounts for a significant number of cancer-related deaths. Its impact is growing in both developed and developing countries.
2. “Metastatic” means spread
The term metastatic simply means the cancer has moved from its original location. Once kidney cancer spreads to other organs, it becomes more difficult to treat and control.
3. Symptoms often appear late
One of the major challenges with kidney cancer is that it can remain silent in its early stages. When symptoms do appear, they may include blood in urine, persistent pain in the side or back, unexplained weight loss, chronic fatigue, fever, or a noticeable lump in the abdomen.
4. Risk factors increase vulnerability
Several factors can raise the risk of developing kidney cancer, including smoking, obesity, uncontrolled high blood pressure, long-term use of certain painkillers, genetic conditions, and family history of cancer. Men are statistically more affected than women, and risk increases with age, especially after 60.
5. Often diagnosed late
A significant number of kidney cancer cases are discovered only after the disease has already spread. This late detection is a key reason why outcomes can be poor in many patients.
6. Survival rates vary
Prognosis for metastatic kidney cancer remains challenging. Survival rates are lower compared to many other cancers, though they have improved in recent years due to medical advances. Some patients respond well to treatment and live significantly longer than expected.
7. Treatment options have expanded
Modern treatment includes targeted therapies, immunotherapy, surgery in select cases, radiation therapy, and palliative care to improve quality of life. Combination therapies have become increasingly important in extending survival and controlling disease progression.
8. Early detection saves lives
When kidney cancer is detected early and remains confined to the kidney, survival rates are very high. This highlights the importance of early medical consultation for warning signs such as persistent back pain or blood in urine.
9. Progression is unpredictable
The course of metastatic kidney cancer varies widely between patients. Some experience rapid progression, while others respond positively to treatment and maintain stability for years, depending on overall health and tumour characteristics.
10. Prevention and awareness are critical
While not all cases are preventable, lifestyle changes can reduce risk. Avoiding smoking, maintaining a healthy weight, managing blood pressure, and seeking prompt medical attention for unusual symptoms are key preventive steps.
